UNIHEALTH

Unihealth Consultancy Share Price

₹149.95 +1.4 (0.94%)

21 Nov, 2024 14:47

SIP TrendupStart SIP in UNIHEALTH

Start SIP

Performance

  • Low
  • ₹149
  • High
  • ₹152
  • 52 Week Low
  • ₹109
  • 52 Week High
  • ₹178
  • Open Price₹149
  • Previous Close₹149
  • Volume10,000

Investment Returns

  • Over 1 Month -2.76%
  • Over 3 Month + 24.49%
  • Over 6 Month + 15.43%
  • Over 1 Year + 7.88%
SIP Lightning

Smart Investing Starts Here Start SIP with Unihealth Consultancy for Steady Growth!

Invest Now

Unihealth Consultancy Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 231
  • P/B Ratio
  • 2.7
  • Average True Range
  • 7.85
  • EPS
  • 6.69
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.15
  • RSI
  • 42.02
  • MFI
  • 66.73

Unihealth Consultancy Financials

Unihealth Consultancy Technicals

EMA & SMA

Current Price
₹149.95
+ 1.4 (0.94%)
pointer
  • stock-down_img
  • Bullish Moving Average 5
  • stock-up_img
  • Bearish Moving Average 11
  • 20 Day
  • ₹157.01
  • 50 Day
  • ₹153.94
  • 100 Day
  • ₹147.32
  • 200 Day
  • ₹142.45

Resistance and Support

149.15 Pivot Speed
  • R3 162.20
  • R2 158.05
  • R1 153.30
  • S1 144.40
  • S2 140.25
  • S3 135.50

What's your outlook on Unihealth Consultancy?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Unihealth Consultancy Ltd has an operating revenue of Rs. 155.73 Cr. on a trailing 12-month basis. An annual revenue growth of 9% is good, Pre-tax margin of 28% is great, ROE of 12% is good. The company has a reasonable debt to equity of 14%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 6% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -15% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 60 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 53 indicates it belongs to a fair industry group of Medical-Managed Care and a Master Score of D is close to being the worst. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Unihealth Consultancy Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-11 Quarterly Results
2024-05-23 Audited Results
2023-11-08 Quarterly Results

Unihealth Consultancy F&O

Unihealth Consultancy Shareholding Pattern

68.93%
0%
0.02%
21.37%
9.68%

About Unihealth Consultancy

  • NSE Symbol
  • UNIHEALTH
  • BSE Symbol
  • Chairman & Managing Director
  • Dr. Akshay M Parmar
  • ISIN
  • INE0PRF01011

Similar Stocks to Unihealth Consultancy

Unihealth Consultancy FAQs

Unihealth Consultancy share price is ₹149 As on 21 November, 2024 | 14:33

The Market Cap of Unihealth Consultancy is ₹230.9 Cr As on 21 November, 2024 | 14:33

The P/E ratio of Unihealth Consultancy is As on 21 November, 2024 | 14:33

The PB ratio of Unihealth Consultancy is 2.7 As on 21 November, 2024 | 14:33

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23